EGFR and neoplasm: To address this limitation, several recent studies have investigated whether EGFR-specific Affibody molecules, which cross-react with EGFR of mouse origin, can delineate EGFR-positive tumors and provide high-contrast tumor imaging in the presence of endogenous background levels of EGFR (15–17).